Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
2.

Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms.

van Ham TJ, Breitling R, Swertz MA, Nollen EA.

EMBO Mol Med. 2009 Nov;1(8-9):360-70. doi: 10.1002/emmm.200900051. Review.

3.

Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes.

Sin O, Nollen EA.

Cell Mol Life Sci. 2015 Nov;72(21):4027-47. doi: 10.1007/s00018-015-1985-0. Epub 2015 Jul 21. Review.

4.

Functional genomics approaches to neurodegenerative diseases.

Rubinsztein DC.

Mamm Genome. 2008 Sep;19(9):587-90. doi: 10.1007/s00335-008-9130-0. Epub 2008 Jul 30. Review.

PMID:
18665420
5.

Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.

Dimitriadi M, Hart AC.

Neurobiol Dis. 2010 Oct;40(1):4-11. doi: 10.1016/j.nbd.2010.05.012. Epub 2010 May 19. Review.

6.

Neurodegenerative conditions associated with ageing: a molecular interplay?

Troulinaki K, Tavernarakis N.

Mech Ageing Dev. 2005 Jan;126(1):23-33. Review.

PMID:
15610759
7.

Molecular genetics approaches in yeast to study amyloid diseases.

Outeiro TF, Muchowski PJ.

J Mol Neurosci. 2004;23(1-2):49-60. Review.

PMID:
15126692
8.

Modeling neurodegenerative diseases in Caenorhabditis elegans.

Li J, Le W.

Exp Neurol. 2013 Dec;250:94-103. doi: 10.1016/j.expneurol.2013.09.024. Epub 2013 Oct 2. Review.

PMID:
24095843
9.

Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins.

Reiter LT, Bier E.

Expert Opin Ther Targets. 2002 Jun;6(3):387-99. Review.

PMID:
12223075
10.

Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.

Hannan SB, Dräger NM, Rasse TM, Voigt A, Jahn TR.

J Neurochem. 2016 Apr;137(1):12-25. doi: 10.1111/jnc.13532. Epub 2016 Feb 11. Review.

12.

Cross-functional E3 ligases Parkin and C-terminus Hsp70-interacting protein in neurodegenerative disorders.

Kumar P, Pradhan K, Karunya R, Ambasta RK, Querfurth HW.

J Neurochem. 2012 Feb;120(3):350-70. doi: 10.1111/j.1471-4159.2011.07588.x. Epub 2011 Dec 21. Review.

13.

Modeling polyglutamine pathogenesis in C. elegans.

Brignull HR, Morley JF, Garcia SM, Morimoto RI.

Methods Enzymol. 2006;412:256-82.

PMID:
17046663
14.

Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases.

Ghosh S, Feany MB.

Hum Mol Genet. 2004 Sep 15;13(18):2011-8. Epub 2004 Jul 14.

PMID:
15254017
15.

Role of molecular chaperones in neurodegenerative disorders.

Meriin AB, Sherman MY.

Int J Hyperthermia. 2005 Aug;21(5):403-19. Review.

PMID:
16048838
16.
17.

Identification of genes that modify ataxin-1-induced neurodegeneration.

Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J.

Nature. 2000 Nov 2;408(6808):101-6.

PMID:
11081516
18.

Genome-wide prediction of C. elegans genetic interactions.

Zhong W, Sternberg PW.

Science. 2006 Mar 10;311(5766):1481-4.

19.

Transgenic invertebrate models of age-associated neurodegenerative diseases.

Link CD.

Mech Ageing Dev. 2001 Sep 30;122(14):1639-49. Review.

PMID:
11511401
20.

Supplemental Content

Support Center